FDA under pressure from right after abortion pill approval
The patience of an anti-miscarriage movement with the Food and Drug Administration (FDA) is diluted after the recent approval of the agency’s second generic version of Mifaprystone, one of the two drugs taken for an abortion. President Trump repeatedly pledged during the campaign last year that he would give up abortion policy to the states,…
